Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 11Relevant journals,13Conferences,10Workshops are presently dedicated exclusively to breathing disorder and about 321 articles are being published on pulmonary tuberculosis.
Pulmonary tuberculosis (TB) is a contagious bacterial infection that involves the lungs. It grows best in areas of the body that have lots of blood and oxygen. That's why it is most often found in the lungs. This is called pulmonary TB. But TB can also spread to other parts of the body, which is called extra pulmonary TB. It may spread to other organs. The bacterium (germ) that causes TB is called Mycobacterium tuberculosis. This germ can cause other kinds of TB, but pulmonary TB is the most common. People who are most at risk for developing TB disease are the elderly, small children, smokers, people who already have an immune system problem, such as HIV, people who do not regularly see a doctor, such as homeless people, people who live in crowded conditions. The symptoms of tuberculosis are- loss of weight, loss of energy, poor appetite, fever, a productive cough, night sweats , breathlessness, extreme tiredness or fatigue and unexplained pain for more than three weeks.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The prevalence of tuberculosis in adult men in India is 2–4 times higher than in women. Tobacco smoking is prevalent almost exclusively among men, so it is possible that tobacco smoking may be a risk factor for developing pulmonary tuberculosis. A nested case control study was carried out to study the association between tobacco smoking and pulmonary tuberculosis. Tuberculosis can cause chronic impairment of lung function which increases incrementally with the number of episodes of tuberculosis. Clearly, prevention of tuberculosis and its effect on lung function is important and can be achieved by early detection and by reduction of the risk of tuberculosis through intervention on risk factors such as HIV, silica dust exposure, silicosis, and socioeconomic factors. Hundreds of studies have evaluated the diagnostic accuracy of nucleic-acid amplification tests (NAATs) for tuberculosis (TB). Commercial tests have been shown to give more consistent results than in-house assays. Previous meta-analyses have found high specificity but low and highly variable estimates of sensitivity. However, reasons for variability in study results have not been adequately explored. We performed a meta-analysis on the accuracy of commercial NAATs to diagnose pulmonary TB and meta-regression to identify factors that are associated with higher accuracy.
Pulmonary tuberculosis (TB) is a contagious bacterial infection that involves the lungs. It grow best in areas of the body that have lots of blood and oxygen. That's why it is most often found in the lungs. This is called pulmonary TB. But TB can also spread to other parts of the body, which is called extrapulmonary TB. It may spread to other organs. The bacterium (germ) that causes TB is called Mycobacterium tuberculosis. This germ can cause other kinds of TB, but pulmonary TB is the most common. People who are most at risk for developing TB disease are the elderly, small children, smokers, people who already have an immune system problem, such as HIV, people who do not regularly see a doctor, such as homeless people, people who live in crowded conditions. The symptoms of tuberculosis are- loss of weight, loss of energy, poor appetite, fever, a productive cough, night sweats , breathlessness, extreme tiredness or fatigue and unexplained pain for more than three weeks. There are different tests for the diagnosis of tuberculosis which includes- Biopsy of the affected tissue, Bronchoscopy, Chest CT scan, Chest x-ray and Tuberculin skin test. Therapy for TB requires a minimum of 6 months of treatment except for culture-negative pulmonary TB. Treatment is initiated when TB is confirmed or strongly suspected and consists of an initial intensive phase and a subsequent continuation phase. Treatment of latent infection is usually with isoniazid for 9 months, or rifampicin for 4 months. If exogenous reinfection is suspected, TB treatment should be based on the drug susceptibility profile of the index case, if known. Pulmonary tuberculosis Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Pulmonary tuberculosis Conference offers excessive quality content to suit the diverse development of medicines and technology to treat people all over the globe. Pulmonary tuberculosis conference is a perfect platform to discuss the current discoveries and developments in the field of Pulmonology. The National Symposium on Pulmonary Tuberculosis offers an opportunity for a diverse group of attendees to network, compare programs, learn about new approaches, and discuss the latest issues facing the development in the field of the treatment of Pulmonary Tuberculosis. The conference is a platform where doctors, clinicians, researchers, health policy makers, physicians, nurses and health professionals can interact and discuss the current and future scenario in the field of Pulmonary Tuberculosis.
Market Analysis:
The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd Rhinology and Otology Conference <br>April 25-27, 2016 Dubai, UAE
4th Bacteriology and Infectious Diseases Conference <br>May 16-18, 2016 San Antonio, USA
2nd Respiratory and Pulmonary Medicine Conference <br>May 09-10, 2016 Chicago, USA
3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK
4th Lung and Respiratory Care Conference <br>Aug-1-3, 2016 Manchester, UK
4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA
Infectious Diseases and Diagnostic Microbiology Conference <br>Oct 3-5, 2016 Vancouver, Canada
2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat centers:
GlaxoSmithKline
Pfizer
Sanofi-Aventis
AstraZeneca
Novartis
Roche
Wyeth
Merk & Co
Lilly
Boehringer Ingelheim
Johnson & Johnson
Schering Plough
Novo Nordisk
Bayer Schering
Abbott
Teva
Bristol-Myers Squibb
Mundi Int
Gilead Sciences
Servier
Edwards Lifesciences
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on December 23, 2024
